{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T08:05:30Z","timestamp":1771661130525,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1053\/j.seminoncol.2014.12.028","type":"journal-article","created":{"date-parts":[[2015,1,3]],"date-time":"2015-01-03T01:33:39Z","timestamp":1420248819000},"page":"272-283","source":"Crossref","is-referenced-by-count":17,"title":["Prevention of Human Papillomavirus\u2013Associated Cancers"],"prefix":"10.1053","volume":"42","author":[{"given":"Joakim","family":"Dillner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2014.12.028_bib1","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.virol.2010.02.002","article-title":"Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments","volume":"401","author":"Bernard","year":"2010","journal-title":"Virology"},{"key":"10.1053\/j.seminoncol.2014.12.028_bib2","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/infdis\/jir383","article-title":"The oral cavity contains abundant known and novel human papillomaviruses from the Betapapillomavirus and Gammapapillomavirus genera","volume":"204","author":"Bottalico","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1053\/j.seminoncol.2014.12.028_bib3","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1099\/vir.0.83178-0","article-title":"Identification and characterization of two novel human papillomaviruses (HPVs) by overlapping PCR: HPV102 and HPV106","volume":"88","author":"Chen","year":"2007","journal-title":"J Gen Virol"},{"key":"10.1053\/j.seminoncol.2014.12.028_bib4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.virol.2009.11.020","article-title":"New generic primer system targeting mucosal\/genital and cutaneous human papillomaviruses leads to the characterization of HPV 115, a novel Beta-papillomavirus species 3","volume":"397","author":"Chouhy","year":"2010","journal-title":"Virology"},{"key":"10.1053\/j.seminoncol.2014.12.028_bib5","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1002\/ijc.26204","article-title":"High throughput sequencing reveals diversity of human papillomaviruses in cutaneous lesions","volume":"129","author":"Ekstrom","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2014.12.028_bib6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.virol.2009.11.027","article-title":"Three novel papillomaviruses (HPV109, HPV112 and HPV114) and their presence in cutaneous and mucosal samples","volume":"397","author":"Ekstrom","year":"2010","journal-title":"Virology"},{"key":"10.1053\/j.seminoncol.2014.12.028_bib7","doi-asserted-by":"crossref","first-page":"e38499","DOI":"10.1371\/journal.pone.0038499","article-title":"Human skin microbiota: high diversity of DNA viruses identified on the human skin by high throughput sequencing","volume":"7","author":"Foulongne","year":"2012","journal-title":"PLoS One"},{"key":"10.1053\/j.seminoncol.2014.12.028_bib8","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1099\/vir.0.030593-0","article-title":"Genomic characterization of ten novel cutaneous human papillomaviruses from keratotic lesions of immunosuppressed patients","volume":"92","author":"Kohler","year":"2011","journal-title":"J Gen Virol"},{"key":"10.1053\/j.seminoncol.2014.12.028_bib9","doi-asserted-by":"crossref","first-page":"11936","DOI":"10.1128\/JVI.01988-12","article-title":"Nine complete genome sequences of cutaneous human papillomavirus genotypes isolated from healthy skin of individuals living in rural He Nan province, China","volume":"86","author":"Li","year":"2012","journal-title":"J Virol"},{"key":"10.1053\/j.seminoncol.2014.12.028_bib10","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1128\/JVI.02490-08","article-title":"E7 oncoprotein of novel human papillomavirus type 108 lacking the E6 gene induces dysplasia in organotypic keratinocyte cultures","volume":"83","author":"Nobre","year":"2009","journal-title":"J Virol"},{"key":"10.1053\/j.seminoncol.2014.12.028_bib11","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1099\/vir.0.2008\/001925-0","article-title":"Four novel human betapapillomaviruses of species 2 preferentially found in actinic keratosis","volume":"89","author":"Vasiljevic","year":"2008","journal-title":"J Gen Virol"},{"key":"10.1053\/j.seminoncol.2014.12.028_bib12","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1099\/vir.0.82679-0","article-title":"Characterization of two novel cutaneous human papillomaviruses, HPV93 and HPV96","volume":"88","author":"Vasiljevic","year":"2007","journal-title":"J Gen Virol"},{"key":"10.1053\/j.seminoncol.2014.12.028_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virol.2004.03.033","article-title":"Classification of papillomaviruses","volume":"324","author":"de Villiers","year":"2004","journal-title":"Virology"},{"key":"10.1053\/j.seminoncol.2014.12.028_bib14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/ijc.11691","article-title":"Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins","volume":"109","author":"Duensing","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2014.12.028_bib15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1750-9378-4-8","article-title":"Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline","volume":"4","author":"Schiffman","year":"2009","journal-title":"Infect Agent Cancer"},{"key":"10.1053\/j.seminoncol.2014.12.028_bib16","series-title":"Monographs on the evaluation of carcinogenic risks to humans volume 100b: a review of human carcinogens: biological agents","year":"2012"},{"issue":"1-2","key":"10.1053\/j.seminoncol.2014.12.028_bib17","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.virol.2013.07.015","article-title":"A systematic review of the prevalence of mucosal and cutaneous human papillomavirus types","volume":"445","author":"Bzhalava","year":"2013","journal-title":"Virology"},{"key":"10.1053\/j.seminoncol.2014.12.028_bib18","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ijc.27663","article-title":"Human papillomavirus types in glandular lesions of the cervix: a meta-analysis of published studies","volume":"132","author":"Guan","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2014.12.028_bib19","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/ijc.27485","article-title":"Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer","volume":"131","author":"Guan","year":"2012","journal-title":"Int J Cancer"},{"issue":"Suppl 5","key":"10.1053\/j.seminoncol.2014.12.028_bib20","doi-asserted-by":"crossref","first-page":"F12","DOI":"10.1016\/j.vaccine.2012.07.055","article-title":"Global burden of human papillomavirus and related diseases","volume":"30","author":"Forman","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"10.1053\/j.seminoncol.2014.12.028_bib21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0959-8049(01)00350-1","article-title":"Estimates of cancer incidence and mortality in Europe in 1995","volume":"38","author":"Bray","year":"2002","journal-title":"Eur J Cancer"},{"issue":"10","key":"10.1053\/j.seminoncol.2014.12.028_bib22","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7326\/0003-4819-132-10-200005160-00009","article-title":"Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review","volume":"132","author":"Nanda","year":"2000","journal-title":"Ann Intern Med"},{"issue":"16","key":"10.1053\/j.seminoncol.2014.12.028_bib23","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa071430","article-title":"Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer","volume":"357","author":"Mayrand","year":"2007","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.seminoncol.2014.12.028_bib24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"issue":"8","key":"10.1053\/j.seminoncol.2014.12.028_bib25","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/sj.bjc.6602799","article-title":"Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting","volume":"93","author":"Kotaniemi-Talonen","year":"2005","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1053\/j.seminoncol.2014.12.028_bib26","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ijc.20076","article-title":"POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women","volume":"110","author":"Bulkmans","year":"2004","journal-title":"Int J Cancer"},{"issue":"16","key":"10.1053\/j.seminoncol.2014.12.028_bib27","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa073204","article-title":"Human papillomavirus and Papanicolaou tests to screen for cervical cancer","volume":"357","author":"Naucler","year":"2007","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1053\/j.seminoncol.2014.12.028_bib28","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1470-2045(06)70731-8","article-title":"Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial","volume":"7","author":"Ronco","year":"2006","journal-title":"Lancet Oncol"},{"issue":"9916","key":"10.1053\/j.seminoncol.2014.12.028_bib29","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"key":"10.1053\/j.seminoncol.2014.12.028_bib30","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrclinonc.2013.84","article-title":"Clinical trials of human papillomavirus vaccines and beyond","volume":"10","author":"Lehtinen","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"10.1053\/j.seminoncol.2014.12.028_bib31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.bjc.6603843","article-title":"HPV type-specific risks of high-grade CIN during 4 years of follow-up: a population-based prospective study","volume":"97","author":"Naucler","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2014.12.028_bib32","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/bmj.g130","article-title":"Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial","volume":"348","author":"Elfstrom","year":"2014","journal-title":"BMJ"},{"issue":"2","key":"10.1053\/j.seminoncol.2014.12.028_bib33","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/ijc.28984","article-title":"Long-term HPV type-specific risks for ASCUS and LSIL: A 14-year follow-up of a randomized primary HPV screening trial","volume":"136","author":"Elfstr\u00f6m","year":"2015","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1053\/j.seminoncol.2014.12.028_bib34","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/ijc.29085","article-title":"Long-term HPV type-specific risks for high-grade cervical intraepithelial lesions: a 14-year follow-up of a randomized primary HPV screening trial","volume":"136","author":"Smelov","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2014.12.028_bib35","doi-asserted-by":"crossref","first-page":"a1754","DOI":"10.1136\/bmj.a1754","article-title":"Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study","volume":"337","author":"Dillner","year":"2008","journal-title":"BMJ"},{"issue":"7","key":"10.1053\/j.seminoncol.2014.12.028_bib36","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(11)70145-0","article-title":"Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice","volume":"12","author":"Katki","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.seminoncol.2014.12.028_bib37","doi-asserted-by":"crossref","first-page":"e670","DOI":"10.1136\/bmj.e670","article-title":"Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model","volume":"344","author":"de Kok","year":"2012","journal-title":"Br Med J"},{"key":"10.1053\/j.seminoncol.2014.12.028_bib38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/GCO.0b013e32835c5d10","article-title":"Primary human papillomavirus testing in organized cervical screening","volume":"25","author":"Dillner","year":"2013","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1053\/j.seminoncol.2014.12.028_bib39","doi-asserted-by":"crossref","first-page":"F100","DOI":"10.1016\/j.vaccine.2012.04.105","article-title":"Nucleic acid tests for the detection of alpha human Papillomaviruses","volume":"S5","author":"Poljak","year":"2012","journal-title":"Vaccine"},{"issue":"11","key":"10.1053\/j.seminoncol.2014.12.028_bib40","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.1128\/JCM.00918-10","article-title":"Human Papillomavirus Laboratory Network. Global proficiency study of human papillomavirus genotyping","volume":"48","author":"Eklund","year":"2010","journal-title":"J Clin Microbiol"},{"issue":"7","key":"10.1053\/j.seminoncol.2014.12.028_bib41","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1128\/JCM.00840-12","article-title":"WHO Human Papillomavirus Laboratory Network. The 2010 global proficiency study of human papillomavirus genotyping in vaccinology","volume":"50","author":"Eklund","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1053\/j.seminoncol.2014.12.028_bib42","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1128\/JCM.02453-13","article-title":"Global improvement in genotyping of human papillomavirus DNA: the 2011 HPV LabNet International Proficiency Study","volume":"52","author":"Eklund","year":"2014","journal-title":"J Clin Microbiol"},{"key":"10.1053\/j.seminoncol.2014.12.028_bib43","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1002\/ijc.27561","article-title":"Randomised healthservice studies","volume":"131","author":"Hakama","year":"2012","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1053\/j.seminoncol.2014.12.028_bib44","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1470-2045(12)70137-7","article-title":"Global burden of cancers attributable to infections in 2008: a review and synthetic analysis","volume":"13","author":"de Martel","year":"2012","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1053\/j.seminoncol.2014.12.028_bib45","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1750-9378-9-4","article-title":"Upscaling human papillomavirus vaccination in high-income countries: impact assessment based on transmission model","volume":"9","author":"Baussano","year":"2014","journal-title":"Infect Agents Cancer"},{"issue":"1","key":"10.1053\/j.seminoncol.2014.12.028_bib46","doi-asserted-by":"crossref","first-page":"dju353","DOI":"10.1093\/jnci\/dju353","article-title":"Translational cancer research: balancing prevention and treatment to combat cancer globally","volume":"107","author":"Wild","year":"2015","journal-title":"J Natl Cancer Inst"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775414002991?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775414002991?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T14:51:12Z","timestamp":1537973472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775414002991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0093775414002991"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2014.12.028","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}